Our Impact

Heart and vascular disease remain the leading cause of death worldwide. We are committed to ending this. Every year we make new discoveries through research and we share our findings to improve the lives of patients worldwide.

230+ Active Research Studies
50+ Educational Event Opportunities
650+ publications
3,000+ patients screened
Hours of Education
99+ Active Research Physicians
Old man smiling

Help us make a difference

With your support-MHIF can continue to offer solutions and hope for so many. You can make a gift through mail, online, using crytpocurrency, through your IRA, or many other options. Find the best way to make your gift.

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approval of the TriClip™

blue background

A new treatment for leaky tricuspid valves has been approved by the FDA. This new therapy is available for patients living with the debilitating effects of tricuspid regurgitation. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial – and going back to the first patient to have access to this technology through research.